Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

40.17
+0.22000.55%
Pre-market: 40.10-0.0700-0.17%04:26 EDT
Volume:765.29K
Turnover:30.70M
Market Cap:3.87B
PE:-20.54
High:41.48
Open:40.20
Low:39.58
Close:39.95
52wk High:42.68
52wk Low:23.23
Shares:96.27M
Float Shares:94.37M
Volume Ratio:1.08
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9561
EPS(LYR):-1.2849
ROE:-16.22%
ROA:-11.54%
PB:3.23
PE(LYR):-31.26

Loading ...

Ideaya Biosciences to Host Investor R&D Day in London

Reuters
·
Sep 01

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Definium Therapeutics (DFTX) and IDEAYA Biosciences (IDYA)

TIPRANKS
·
Aug 31

Ideaya Targets Year-End 2026 Start for Phase 3 Ide849 Trial in Extensive-Stage Small Cell Lung Cancer

Reuters
·
Aug 31

Ideaya Biosciences, - to Initiate Phase 3 Trial for Ide849 by Year-End 2026 in Es-Sclc

THOMSON REUTERS
·
Aug 31

Ideaya Biosciences Announces Successful FDA Type C Meeting for Ide849, Dll3 Top1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer

THOMSON REUTERS
·
Aug 31

Ideaya Biosciences Grants Inducement Stock Options for 62,800 Shares at USD 41.77 Each

Reuters
·
Aug 28

Ideaya Biosciences Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 28

Wedbush Keeps Their Buy Rating on IDEAYA Biosciences (IDYA)

TIPRANKS
·
Aug 20

Analysts Conflicted on These Healthcare Names: IDEAYA Biosciences (IDYA) and Definitive Healthcare Corp (DH)

TIPRANKS
·
Aug 20

Ideaya Biosciences, Genentech Partner for Pancreatic Cancer Trial

MT Newswires Live
·
Aug 19

Ideaya Biosciences enters IDE892 collaboration with Genentech

TIPRANKS
·
Aug 19

Ideaya Biosciences Teams with Genentech to Test Ide892 with KRAS G12D Drug in Pancreatic Cancer

Reuters
·
Aug 19

Ideaya Biosciences - to Supply Ide892 for Clinical Trial

THOMSON REUTERS
·
Aug 19

Ideaya Biosciences - Plans to Initiate a Phase 1 Combination Cohort with Roche's Rg6505 in Mtap-Deleted, Ras-Mutant Pdac in 2H 2026

THOMSON REUTERS
·
Aug 19

Ideaya Biosciences Announces Clinical Collaboration with Genentech in Mtap-Deleted Kras G12d-Mutant Pancreatic Cancer

THOMSON REUTERS
·
Aug 19

Ideaya Biosciences - Co and Genentech Retain All Commercial Rights to Their Compounds

THOMSON REUTERS
·
Aug 19

Ideaya Biosciences, - Genentech to Sponsor Clinical Trial with Joint Governance

THOMSON REUTERS
·
Aug 19

LifeSci Capital Sticks to Its Buy Rating for IDEAYA Biosciences (IDYA)

TIPRANKS
·
Aug 08

Ideaya Biosciences price target lowered to $42 from $45 at Citizens

TIPRANKS
·
Aug 07

IDEAYA Biosciences (IDYA) Receives a Buy from RBC Capital

TIPRANKS
·
Aug 06